Here’s how CPI Enterprises connects investors and entrepreneurs across the UK to stimulate the growth of advanced technology companies.
May 01 2023
Blog
Big Concepts in Brief: What are Oligonucleotides?
Claire answers some of the most frequently asked questions about oligonucleotides, from a basic definition to their potential within the pharma industry.
Apr 28 2023
Blog
Our journey to embedding impact at the heart of CPI
What does embedding impact really mean for technology innovation at CPI? Our Director of Impact, Louise Barker, looks back on this journey.
Apr 19 2023
Blog
The future of digital health: overcoming the sector’s main challenges
Digital health is one of the largest healthcare markets, growing by 20% each year. At CPI, we’re dedicated to helping this sector reach its full potential.
Apr 04 2023
Blog
What is impact?
We see the word “impact” cropping up more and more in business. But what does it mean, really? How should we define impact? And how do we measure it?
Mar 21 2023
News
Scaling up e‑waste recycling with Descycle investment
CPI Enterprises invests in disruptive deep tech company, Descycle, who offer a clean and efficient metal processing alternative to traditional smelting.
Mar 17 2023
Blog
Meet the Team: CPI Enterprises
A collaborative team with an incredible culture, aligned vision and powerful leadership enables us to deliver exceptional returns for our stakeholders.
Mar 10 2023
News
New consortium aims to expand patient access to life-saving oligonucleotide therapeutics
CPI is set to boost oligonucleotide manufacture through a £2.7 million 3‑year partnership with AstraZeneca, Novartis, and The University of Manchester.
Feb 28 2023
Blog
Meet the Team: Lara Picknett, Apprentice Scientist
Through my CPI degree-level apprenticeship, I’m developing skills that’ll last a lifetime, growing in confidence and working with diverse people.
